The objective of this IAA is to develop critical reagents (to include inactivated antigenic materials, nucleic acids and antibodies) for use in basic research and product development activities for Category A-C pathogens.

Agency
National Institute of Health (NIH)
Type
NIH Inter-Agency Agreements (Y01)
Project #
AAI12038001-1-0-1
Application #
8919533
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2014
Total Cost
Indirect Cost
City
State
Country
Zip Code